MET-P-A vs BBIO

Comparison between Metlife Inc (MET-P-A, Company) and BridgeBio Pharma Inc (BBIO, Company).

5-Year PerformanceBBIO has outperformed MET-P-A, delivering a return of +2.9% compared to +2.8%

MET-P-A vs BBIO - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MET-P-A(COMPANY)	BBIO(COMPANY)
Market Cap	$14B	$14B
Max Drawdown	33.29%	92.80%
Sharpe Ratio	-0.93	1.13
5Y Beta	0.21	1.03
Industry	N/A	Biotechnology
P/E Ratio	3.82	-18.39
PEG Ratio	N/A	-3.28
5Y Dividends CAGR	9.40%	N/A
5Y EPS CAGR	29.35%	-3.14%
Debt to Equity	1.48%	-116.44%
Free Cash Flow Yield	N/A	-3.28%
P/S Ratio	N/A	23.42
P/B Ratio	N/A	123.68

Market Cap

Winner

MET-P-A

$14B

BBIO

$14B

Max Drawdown

Winner

MET-P-A

33.29%

BBIO

92.80%

Sharpe Ratio

MET-P-A

-0.93

Winner

BBIO

1.13

5Y Beta

Winner

MET-P-A

0.21

BBIO

1.03

Industry

MET-P-A

N/A

BBIO

Biotechnology

P/E Ratio

MET-P-A

3.82

Winner

BBIO

-18.39

PEG Ratio

MET-P-A

N/A

BBIO

-3.28

5Y Dividends CAGR

MET-P-A

9.40%

BBIO

N/A

5Y EPS CAGR

Winner

MET-P-A

29.35%

BBIO

-3.14%

Debt to Equity

MET-P-A

1.48%

Winner

BBIO

-116.44%

Free Cash Flow Yield

MET-P-A

N/A

BBIO

-3.28%

P/S Ratio

MET-P-A

N/A

BBIO

23.42

P/B Ratio

MET-P-A

N/A

BBIO

123.68

MET-P-A vs BBIO - Historical Returns

Returns include dividend reinvestment.

Period	MET-P-A	BBIO
1 month	-4.79%	+2.89%
3 months	+0.16%	-2.68%
6 months	+0.38%	-8.94%
1 year	-3.51%	+57.03%
5 years(CAGR)	+2.84%	+2.89%
10 years(CAGR)	+4.27%	N/A
Max(CAGR)	+4.87%	+14.19%

MET-P-A

-4.79%

Winner

BBIO

+2.89%

Winner

MET-P-A

+0.16%

BBIO

-2.68%

Winner

MET-P-A

+0.38%

BBIO

-8.94%

MET-P-A

-3.51%

Winner

BBIO

+57.03%

5Y(CAGR)

MET-P-A

+2.84%

Winner

BBIO

+2.89%

10Y(CAGR)

MET-P-A

+4.27%

BBIO

N/A

Max(CAGR)

MET-P-A

+4.87%

Winner

BBIO

+14.19%

MET-P-A vs BBIO - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	MET-P-A	BBIO
2026	+0.94%	-10.92%
2025	-7.42%	+171.24%
2024	+17.75%	-32.16%
2023	+13.94%	+463.04%
2022	-9.51%	-55.59%
2021	+6.20%	-73.79%
2020	+6.92%	+114.06%
2019	+23.44%	+27.22%
2018	-10.67%	N/A
2017	+11.86%	N/A
2016	-2.66%	N/A
2015	+11.52%	N/A
2014	-2.75%	N/A

MET-P-A vs BBIO Drawdown Comparison

The maximum drawdown for MET-P-A was -31.44%, occurring on Mar 23, 2020. Recovery took 117 trading sessions.

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The current MET-P-A drawdown is -8.05%. The current BBIO drawdown is -12.79%.

Rank	MET-P-A	BBIO
#1	-31.44% Mar 4, 2020 - Aug 19, 2020	-92.80% Feb 8, 2021 - Dec 3, 2025
#2	-20.61% Jul 10, 2018 - Jul 19, 2019	-65.45% Dec 23, 2019 - Nov 24, 2020
#3	-20.44% Aug 5, 2021 - Mar 8, 2023	-44.53% Sep 3, 2019 - Nov 20, 2019
#4	-10.87% Sep 29, 2025 - Mar 31, 2026	-21.99% Dec 31, 2020 - Feb 8, 2021
#5	-10.42% Feb 28, 2025 - Sep 29, 2025	-20.25% Jan 22, 2026 - Feb 5, 2026
#6	-9.21% Apr 24, 2023 - Sep 29, 2023	-16.79% Nov 22, 2019 - Dec 9, 2019
#7	-8.64% Oct 21, 2016 - Mar 22, 2017	-14.67% Jul 22, 2019 - Aug 26, 2019
#8	-7.91% Nov 27, 2015 - Mar 1, 2016	-12.87% Jul 11, 2019 - Jul 22, 2019
#9	-5.36% Oct 20, 2017 - Feb 27, 2018	-6.70% Dec 12, 2019 - Dec 18, 2019
#10	-5.21% Nov 26, 2014 - Feb 3, 2015	-6.15% Jan 2, 2026 - Jan 13, 2026
#11	-5.13% Jul 11, 2024 - Sep 5, 2024	-5.62% Jul 5, 2019 - Jul 11, 2019
#12	-4.41% Mar 8, 2023 - Mar 31, 2023	-5.28% Aug 27, 2019 - Sep 3, 2019
#13	-4.17% Jun 2, 2015 - Oct 22, 2015	-4.46% Dec 1, 2020 - Dec 4, 2020
#14	-4.04% Feb 20, 2020 - Mar 4, 2020	-4.45% Dec 18, 2019 - Dec 20, 2019
#15	-3.72% Sep 29, 2023 - Nov 3, 2023	-4.13% Dec 4, 2025 - Dec 12, 2025

Correlation

Correlation between MET-P-A and BBIO is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.40

-101